Raffles Medical Group Ltd (BSL)
📊 Statistics
-
Analyst 1 Year Price Target:
$1.10
-
Upside/Downside from Analyst Target:
11.86%
-
Broker Call:
11
-
Dividend Minimum 3 Year Yield:
2.31%
-
EPS Growth Range (1Y):
<0%
-
Net Income Growth Range (1Y):
<0%
-
Revenue Growth Range (1Y):
0-10%
💰 Dividend History
📅 SGX Earnings Announcements for BSL
Raffles Medical Group Ltd (BSL)
Market: SGX |
Currency: SGD
Address: 585 North Bridge Road
Raffles Medical Group Ltd provides integrated private healthcare services primarily in Singapore, Greater China, Vietnam, Cambodia, and Japan. The company operates through Healthcare Services, Hospital Services, Investment Holdings, and Insurance Services segments. Its Raffles Hospital, a tertiary care hospital that offers a range of medical and surgical facilities include day angiography suites, operating theatres, delivery suites, intensive care unit, neonatal intensive care unit, radiology, clinical laboratory, and dental services. In addition, the company offers emergency services, family medicine services, health screening, minor surgery, and various specialist clinic services. Further, it trades in pharmaceutical and nutraceutical products, and diagnostic equipment; and provides management and consultancy services. Additionally, the company engages in the operation of medical and dental clinics and other general medical services; provides medical examination and treatment services; operation of medical laboratory and imaging centre; and provision of health insurance services. Raffles Medical Group Ltd was founded in 1976 and is based in Singapore. The company operates as a subsidiary of Raffles Medical Holdings Pte Ltd.
Show more
📈 Raffles Medical Group Ltd Historical Chart
📰 Related News & Research
-
Raffles Medical Group (RFMD SP): Strong Immunity, Shanghai Collaboration – Maybank Research Report
April 26, 2025
Maybank Research Pte Ltd April 23, 2025 Raffles Medical Group: Strong Immunity – Strategic Shanghai Collaboration Drives Target Price Increase Executive Summary Raffles Medical Group…
-
Raffles Medical Group Ltd: Uptrend in Early Stage – Technical Buy Recommendation
April 16, 2025
CGS International Securities Pte. Ltd. April 16, 2025 Trendspotter: Raffles Medical Group Ltd – Uptrend in an Early Stage The global market experienced significant fluctuations…
-
Wilmar International (WIL), Japfa Ltd (JAP), Sea Limited (SE), Grab Holdings (GRAB), Raffles Medical Group (RMG)
September 2, 2024
Wilmar International Ltd (WIL SP) – Benefiting from Higher Swine Prices and Stronger Currencies Recommendation: ADD Target Price: S$3.64 Stop Loss: None specified Date of…
🔍 View more Reports